Association between albuminuria, incident cardiovascular events, and mortality in persons without hypertension, diabetes, and cardiovascular disease

Abstract

2] In current clinical practice, albuminuria screening is predominantly performed in the staging of kidney disease or in persons with hypertension or diabetes as a marker for end-target organ damage. It remains unclear if albuminuria screening for CV risk assessment should be extended to persons without diabetes and hypertension. Our aim was to investigate the association between albuminuria and 10-year risk of a composite CV outcome in adults without hypertension or diabetes in the UK Biobank study.

Topics & Concepts